Flying rocket

Saroja Pharma Industries India Ltd

Saroja Pharma Industries India Ltd

₹ 52.8 -3.91%
29 Oct - close price
About

Incorporated in 2023, Saroja Pharma Ltd is mainly in the business of trading Thionyl Chloride chemical and pharmaceutical intermeddles, etc.[1]

Key Points

Business Overview:[1]
SPIIL is in the business of trading in Pharma API, Pharma Intermediates, Chemicals, Solvents, and other pharmaceutical products, used
for human and veterinary medicine

  • Market Cap 21.2 Cr.
  • Current Price 52.8
  • High / Low 70.8 / 33.1
  • Stock P/E 24.2
  • Book Value 36.4
  • Dividend Yield 0.00 %
  • ROCE 14.9 %
  • ROE 8.92 %
  • Face Value 10.0

Pros

  • Company has reduced debt.

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has low interest coverage ratio.
  • Debtor days have increased from 106 to 146 days.
  • Company's cost of borrowing seems high

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Trading Industry: Trading

Loading peers table ...

Half Yearly Results

Figures in Rs. Crores

Sep 2022 Mar 2023 Sep 2023 Mar 2024
26.54 23.73 21.12 19.36
25.18 22.28 19.95 18.17
Operating Profit 1.36 1.45 1.17 1.19
OPM % 5.12% 6.11% 5.54% 6.15%
0.08 0.00 0.39 0.00
Interest 0.68 0.64 0.83 0.62
Depreciation 0.00 0.07 0.04 0.06
Profit before tax 0.76 0.74 0.69 0.51
Tax % 27.63% 27.03% 27.54% 27.45%
0.55 0.54 0.50 0.38
EPS in Rs 24.36 1.84 1.24 0.95
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2021 Mar 2022 Mar 2023 Mar 2024
36.66 55.63 50.19 40.67
35.36 53.53 47.47 38.11
Operating Profit 1.30 2.10 2.72 2.56
OPM % 3.55% 3.77% 5.42% 6.29%
0.09 0.32 0.16 0.19
Interest 0.33 0.80 1.32 1.45
Depreciation 0.02 0.05 0.07 0.09
Profit before tax 1.04 1.57 1.49 1.21
Tax % 28.85% 28.03% 28.86% 27.27%
0.73 1.14 1.06 0.88
EPS in Rs 730.00 50.49 3.61 2.19
Dividend Payout % 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 4%
TTM: -19%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 6%
TTM: -17%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -16%
Return on Equity
10 Years: %
5 Years: %
3 Years: 18%
Last Year: 9%

Balance Sheet

Figures in Rs. Crores

Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 0.01 0.23 2.94 4.02
Reserves 0.93 3.80 2.15 10.62
3.02 6.14 10.18 5.73
4.26 5.34 6.07 6.20
Total Liabilities 8.22 15.51 21.34 26.57
0.09 0.34 2.22 2.51
CWIP 0.00 0.00 1.79 6.13
Investments 0.00 0.04 0.14 0.20
8.13 15.13 17.19 17.73
Total Assets 8.22 15.51 21.34 26.57

Cash Flows

Figures in Rs. Crores

Mar 2021 Mar 2022 Mar 2023 Mar 2024
-1.05 -3.67 2.19 1.02
-0.05 -0.34 -4.82 -4.76
1.03 4.27 2.73 3.70
Net Cash Flow -0.07 0.26 0.10 -0.04

Ratios

Figures in Rs. Crores

Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 71.88 91.73 80.80 145.75
Inventory Days 7.23 3.41 31.18 4.10
Days Payable 45.43 38.52 47.22 57.45
Cash Conversion Cycle 33.68 56.62 64.76 92.39
Working Capital Days 38.13 62.20 70.83 99.62
ROCE % 33.55% 22.09% 14.93%

Shareholding Pattern

Numbers in percentages

1 Recently
Sep 2023Mar 2024Sep 2024
73.02% 73.02% 73.02%
26.99% 26.98% 26.98%
No. of Shareholders 597506438

Documents